NCT00649779View on ClinicalTrials.gov

Fasting Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Healthy
Interventions
DRUG

albuterol sulfate extended-release 8 mg tablets

8mg, single dose fasting

DRUG

VoSpire™ ER 8 mg tablets

8mg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00649779 - Fasting Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg | Biotech Hunter | Biotech Hunter